IL17A and Parkinson disease: Additionally, meta-analyses have demonstrated significantly elevated IL-17 levels in PD patients (Gautam et al., 2023), leading us to speculate that circulating inflammatory proteins may mediate the pathway from plasma lipidome to PD.